JP2011157365A5 - - Google Patents

Download PDF

Info

Publication number
JP2011157365A5
JP2011157365A5 JP2011051681A JP2011051681A JP2011157365A5 JP 2011157365 A5 JP2011157365 A5 JP 2011157365A5 JP 2011051681 A JP2011051681 A JP 2011051681A JP 2011051681 A JP2011051681 A JP 2011051681A JP 2011157365 A5 JP2011157365 A5 JP 2011157365A5
Authority
JP
Japan
Prior art keywords
glycoprotein
derivative
group
protein
retarding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011051681A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011157365A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011157365A publication Critical patent/JP2011157365A/ja
Publication of JP2011157365A5 publication Critical patent/JP2011157365A5/ja
Withdrawn legal-status Critical Current

Links

JP2011051681A 2003-08-08 2011-03-09 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用 Withdrawn JP2011157365A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DKPA200301145 2003-08-08
DKPA200301145 2003-08-08
US49444703P 2003-08-12 2003-08-12
US60/494,447 2003-08-12
DKPA200301646 2003-11-05
DKPA200301646 2003-11-05
US51921203P 2003-11-12 2003-11-12
US60/519,212 2003-11-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006522893A Division JP2007501811A (ja) 2003-08-08 2004-08-09 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。

Publications (2)

Publication Number Publication Date
JP2011157365A JP2011157365A (ja) 2011-08-18
JP2011157365A5 true JP2011157365A5 (cg-RX-API-DMAC7.html) 2012-06-14

Family

ID=34139681

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006522893A Withdrawn JP2007501811A (ja) 2003-08-08 2004-08-09 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。
JP2006522894A Pending JP2007501812A (ja) 2003-08-08 2004-08-09 ペプチドのための結合剤として新しい構造上十分に定義された枝分れしたポリマーの合成および適用
JP2011051681A Withdrawn JP2011157365A (ja) 2003-08-08 2011-03-09 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2006522893A Withdrawn JP2007501811A (ja) 2003-08-08 2004-08-09 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。
JP2006522894A Pending JP2007501812A (ja) 2003-08-08 2004-08-09 ペプチドのための結合剤として新しい構造上十分に定義された枝分れしたポリマーの合成および適用

Country Status (3)

Country Link
EP (2) EP1653996A2 (cg-RX-API-DMAC7.html)
JP (3) JP2007501811A (cg-RX-API-DMAC7.html)
WO (2) WO2005014035A2 (cg-RX-API-DMAC7.html)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
WO2004032971A1 (en) 2002-10-08 2004-04-22 Fresenius Kabi Deutschland Gmbh Pharmaceutically active oligosaccharide conjugates
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
US20060228331A1 (en) 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
DE602004029173D1 (de) * 2003-10-10 2010-10-28 Novo Nordisk As Il-21-derivate
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
CA2565414A1 (en) 2004-05-04 2005-11-24 Novo Nordisk Health Care Ag O-linked glycoforms of polypeptides and method to manufacture them
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
EP1814573B1 (en) 2004-10-29 2016-03-09 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
CA2593682C (en) 2005-01-10 2016-03-22 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
US20090036353A1 (en) * 2005-01-27 2009-02-05 Novo Nordisk A/S Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers
MX2007009906A (es) * 2005-02-16 2007-09-25 Novo Nordisk As Derivados de agentes insulinotropicos conjugados con polimeros ramificados estructuralmente bien definidos.
JP2008532966A (ja) * 2005-03-11 2008-08-21 フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 不活性出発物質からの生理活性糖タンパク質の生成
WO2006094826A2 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Method for coupling enzymatically activated glycoconjugates to a hydroxyalkyl starch
TWI362392B (en) 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
ES2484796T3 (es) 2005-03-18 2014-08-12 Novo Nordisk A/S Compuestos de GLP-1 extendidos
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
CA2611823C (en) 2005-06-16 2013-07-30 Nektar Therapeutics Al, Corporation Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
RS51319B (sr) 2005-09-22 2010-12-31 Biocompatibles Uk Limited GLP-l (GLUKAGON-LIKE PEPTID-l) FUZIONI POLIPEPTIDI SA POVEĆANOM OTPORNOSTI NA PEPTIDAZE
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
CU23556A1 (es) 2005-11-30 2010-07-20 Ct Ingenieria Genetica Biotech Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico
WO2007075534A2 (en) 2005-12-16 2007-07-05 Nektar Therapeutics Al, Corporation Polymer conjugates of glp-1
EP1854455B1 (en) 2006-05-10 2009-10-07 Biocompatibles UK Limited Spherical microcapsules comprising GLP-1 peptides, their production and use
US8268948B2 (en) 2006-07-21 2012-09-18 Nektar Therapeutics Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
US20100056428A1 (en) 2006-09-01 2010-03-04 Novo Nordisk Health Care Ag Modified proteins
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
DK2101821T3 (da) 2006-12-15 2014-10-06 Baxter Healthcare Sa Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo
WO2008082613A2 (en) 2006-12-27 2008-07-10 Nektar Therapeutics Al, Corporation Factor ix moiety-polymer conjugates having a releasable linkage
MX2009007145A (es) 2006-12-27 2009-08-27 Nektar Therapeutics Al Corp Conjugados de polimero con factor viii y factor de von willebrand que tienen una ligadura liberable.
CN102978185B (zh) 2007-01-18 2015-02-11 建新公司 包含氨基氧基基团的寡糖及其轭合物
EP2144923B1 (en) 2007-04-03 2013-02-13 BioGeneriX AG Methods of treatment using glycopegylated g-csf
EP2157967B1 (en) * 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
US20130189239A1 (en) 2008-02-27 2013-07-25 Novo Nordisk A/S Conjugated Factor VIII Molecules
WO2010015668A1 (en) 2008-08-06 2010-02-11 Novo Nordisk A/S Conjugated proteins with prolonged in vivo efficacy
EP3608330B1 (en) 2008-12-16 2022-11-09 Genzyme Corporation Synthetic intermediates for preparing oligosaccharide-protein conjugates
JP5816097B2 (ja) 2009-01-22 2015-11-18 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
JP5418360B2 (ja) 2009-03-27 2014-02-19 日油株式会社 ポリオキシアルキレン誘導体の製造方法
RU2744370C2 (ru) 2009-07-27 2021-03-05 Баксалта Инкорпорейтед Конъюгаты белков свертывания крови
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
BR112012001814A8 (pt) 2009-07-27 2018-02-06 Baxalta GmbH Conjugados de proteína de coagulação sanguínea
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
EP3081233B1 (en) * 2009-07-27 2020-12-23 Baxalta GmbH Glycopolysialylation of proteins other than blood coagulation proteins
WO2011015649A1 (en) 2009-08-06 2011-02-10 Novo Nordisk Health Care Ag Growth hormones with prolonged in-vivo efficacy
EP2507267B1 (en) 2009-12-02 2016-09-14 Acceleron Pharma, Inc. Compositions and methods for increasing serum half-life of fc fusion proteins
US20120329711A1 (en) * 2009-12-16 2012-12-27 Nordisk A/S Glp-1 receptor agonist compounds with a modified n-terminus
PL2525834T3 (pl) 2010-01-22 2020-10-19 Novo Nordisk Health Care Ag Hormony wzrostu o przedłużonej skuteczności in-vivo
RU2012134974A (ru) 2010-01-22 2014-02-27 Ново Нордиск Хелс Кеа Аг Стабилизированное соединение гормона роста
MX375112B (es) 2010-07-09 2025-03-06 Biogen Hemophilia Inc Polipéptidos de factor ix y métodos para usarlos.
MX377589B (es) 2010-12-16 2025-03-10 Novo Nordisk As Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico.
ES2800983T3 (es) 2010-12-22 2021-01-07 Baxalta GmbH Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína
US8901341B2 (en) * 2011-02-11 2014-12-02 Bezwada Biomedical, Llc Amino acid derivatives and absorbable polymers therefrom
AU2012241894B2 (en) 2011-04-12 2015-12-03 Novo Nordisk A/S Double-acylated GLP-1 derivatives
US8883982B2 (en) 2011-06-08 2014-11-11 Acceleron Pharma, Inc. Compositions and methods for increasing serum half-life
US9790305B2 (en) * 2011-09-09 2017-10-17 Franklin And Marshall College Site specifically incorporated initiator for growth of polymers from proteins
KR102072202B1 (ko) 2012-03-22 2020-01-31 노보 노르디스크 에이/에스 Glp-1 펩티드의 조성물 및 그것의 제조
ES2715308T3 (es) 2012-03-22 2019-06-03 Novo Nordisk As Composiciones que comprenden un agente de suministro y su preparación
WO2013189988A1 (en) 2012-06-20 2013-12-27 Novo Nordisk A/S Tablet formulation comprising a peptide and a delivery agent
US9790268B2 (en) 2012-09-12 2017-10-17 Genzyme Corporation Fc containing polypeptides with altered glycosylation and reduced effector function
JP2015533152A (ja) 2012-10-15 2015-11-19 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 第vii因子コンジュゲート
ES2841123T3 (es) 2013-04-05 2021-07-07 Formulacion Del Compuesto De La Hormona De Crecimiento Formulación del compuesto de la hormona de crecimiento
RS58039B1 (sr) 2013-05-02 2019-02-28 Novo Nordisk As Oralno doziranje glp-1 jedinjenja
CA2927756A1 (en) 2013-10-15 2015-04-23 Novo Nordisk Health Care Ag Coagulation factor vii polypeptides
HUE061339T2 (hu) * 2014-03-19 2023-06-28 Genzyme Corp Targetáló csoportok helyspecifikus glikotechnikai átalakítása
KR20170010003A (ko) * 2014-05-27 2017-01-25 아카데미아 시니카 박테로이드 기원의 푸코시다제 및 이의 사용 방법
US20180045734A1 (en) * 2015-03-06 2018-02-15 Tymora Analytical Operations Llc Chemically functionalized array to analyze protein modifications
CN106478806B (zh) * 2016-10-24 2019-08-30 合肥国肽生物科技有限公司 一种索玛鲁肽的固相合成方法
AR114353A1 (es) 2018-02-02 2020-08-26 Novo Nordisk As Composiciones sólidas que comprenden un agonista del glp-1 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico
MX2023007965A (es) * 2021-01-04 2023-08-14 Biocon Ltd Sintesis de teduglutida.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU583854B2 (en) * 1984-09-13 1989-05-11 Cytogen Corporation Antibody therapeutic agent conjugates
AU1676992A (en) * 1991-03-18 1992-10-21 Enzon, Inc. Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
US6326353B1 (en) * 1993-03-23 2001-12-04 Sequus Pharmaceuticals, Inc. Enhanced circulation effector composition and method
US6180134B1 (en) * 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
WO1994028024A1 (en) * 1993-06-01 1994-12-08 Enzon, Inc. Carbohydrate-modified polymer conjugates with erythropoietic activity
MX9504664A (es) * 1994-03-07 1997-05-31 Dow Chemical Co Conjugados de dendrimeros bioactivos y/o dirigidos.
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
AU5920096A (en) * 1995-05-15 1996-11-29 Constantin A. Bona Carbohydrate-mediated coupling of peptides to immunoglobulins
AU720860B2 (en) * 1996-10-08 2000-06-15 Macquarie Research Limited Glycan derivatives
JP2927291B2 (ja) * 1997-09-01 1999-07-28 東洋インキ製造株式会社 ビニル基含有デンドリマー
US6485718B1 (en) * 1999-04-13 2002-11-26 Pharmacia Corporation Site specific ligation of proteins to synthetic particles
JP2003503591A (ja) * 1999-06-29 2003-01-28 ダコ エー エス 標識およびプローブを保持するデンドリマーを用いた検出
WO2001058935A2 (en) * 2000-02-11 2001-08-16 Maxygen Aps FACTOR VII OR VIIa-LIKE MOLECULES
MXPA03000310A (es) * 2000-07-12 2004-12-13 Gryphon Therapeutics Inc Quimiocinas sinteticas bioactivas, modificadas con polimeros y metodos para su elaboracion y uso.
AU2002240312A1 (en) * 2001-02-08 2002-08-19 Pankaj Paranjp Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates
EP1446438A2 (en) * 2001-11-07 2004-08-18 Nektar Therapeutics Al, Corporation Branched polymers and their conjugates

Similar Documents

Publication Publication Date Title
CA2677041C (en) Multimeric conjugate
Yang et al. Tailoring structure–function and pharmacokinetic properties of single‐chain Fv proteins by site‐specific PEGylation
EP2125864B1 (en) Affinity separation by partition enhancing material conjugated biomolecules in aqueous two-phase extraction system
Azevedo et al. Affinity-enhanced purification of human antibodies by aqueous two-phase extraction
CN102575244B (zh) 抗生物素蛋白与生物素衍生物的解离方法以及解离剂
US20210107937A1 (en) Selective enrichment of antibodies
JP2001500528A (ja) 新規糖タンパク質
JP2016520655A (ja) タンパク質精製プロセス
EP2205641B1 (en) Method for preparing antibody monolayers which have controlled orientation using peptide hybrid
JP2008540726A5 (cg-RX-API-DMAC7.html)
JP2003503591A (ja) 標識およびプローブを保持するデンドリマーを用いた検出
JP2015520163A5 (cg-RX-API-DMAC7.html)
TW202346322A (zh) 含Fc分子之製造方法
JP5866880B2 (ja) 生理活性物質固定化用粒子、生理活性物質固定粒子及び糖親和性物質捕捉粒子
KR101776976B1 (ko) 생체분자의 활성화 및 접합 방법
KR20200043990A (ko) 크로마토그래피용 담체, 리간드 고정 담체, 크로마토그래피 칼럼, 표적 물질의 정제 방법 및 크로마토그래피용 담체의 제조 방법
CN105289558B (zh) 多组分嵌段亲水共聚物‑硅胶杂化色谱填料的制备及应用
WO2003059987A1 (en) Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it
CN102770438B (zh) 通过在多个单体与特异性结合单体的粘合体的重复链的复合物中增加键桥的产量以生产二聚体和多聚体的方法
JP4911415B2 (ja) 非特異性吸着抑制材料
JP2007112679A (ja) ナノ粒子及びその製造方法
JP7578907B2 (ja) バイオチップおよび検出方法
US20140329290A1 (en) Novel branched polyethylene glycol and use thereof
Boas et al. Poly (lysine) dendrimers and other dendritic molecules from naturally occurring monomers
TWI333066B (en) Method for separating nanoparticles with a controlled number of active groups